Oncology/Haematology

Oncology/haematology market researchOncology has always been a complex area to treat and research, with multiple indications and different treatments at different stages all adding to the complexity.

Over recent years the treatment of cancer has been revolutionised by a plethora of new treatments – which add complexity to clinicians choosing regimens and for marketer researchers trying to understand and predict their decisions. They also pose challenges to payers, meaning marketers increasingly need helping navigating the challenges posed by changing access environments.

More change is on the horizon. Many tumour types will be revolutionized over the next few years with the emergence of immune-oncology treatments. Many are targeted to patients with specific mutations but the high cost of theses treatments is non the less likely to raise interesting access challenges.

Experienced Consultants in Oncology/Haematology

Our Therapy Area Team will work closely with you to help identify the most suitable approach, challenge when necessary and provide actionable insights to help navigate your marketing challenges. We have dedicated Senior Consultants and Therapy Area Teams that keep abreast of the full market landscape.

Adelphi MarketMapTM

Adelphi-Market-MapsAdelphi MarketMapsTM have been developed to summarise and visualise the full market landscape including the key challengers, market trends and the likely impact of pipeline treatments.

Contact us for a copy of Adelphi MarketMapsTM in Oncology/Haematology

Oncology-&-Haematology-Market-Research

The Types of Challenges We help to Solve

  • Future of cancer drugs cross portfolio
  • Sizing private sector opportunities
  • Optimising positioning in the new metastatic breast cancer environment
  • Optimising pricing and reimbursement strategies
  • Understanding the patient journey and experiences
  • Campaign development and testing, ensuring campaigns reflect reality